Trial Condition(s):

Tinea

Tolerability and efficacy of bifonazole gel 1% in the treatment of Tinea pedis and Tinea cruris

Bayer Identifier:

Trial_0402

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

120

Trial Dates

June1987

Phase

N/A

Could I receive a placebo?

Products

Mycospor/Canesten Extra (Bifonazole, BAYH4502)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

For details, please refer to trial results

Additional Information

Not Available

Tinea

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

1 Years

79 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information